While OPN has shown promise in reflecting inflammatory and atherosclerotic activity, its utility as a standalone marker is limited by methodological heterogeneity, variations in study cohorts, and the influence of pathological confounders like systemic inflammation, diabetes, and renal dysfunction. Here, SPP1 is linked to Abnormal renal physiology.